BIRC5 and glioblastoma: Beyond clonal selection, we identified another mechanism, showing in vitro that subtoxic, clinically relevant IR doses trigger a survivin-mediated plasticity process, shifting resistant differentiated GBM cells towards a more stem-like state [10].